COR vs CAH vs MCK
161 measures in 16 categories, one definition each, computed from filings and market data.
CAH58.6
Cardinal Health, Inc.
Healthcare · Medical - Distribution
$254.06 +0.14%$58.8B mkt cap
Score DNA
MCK60.4
McKesson Corporation
Healthcare · Medical - Distribution
$1,004.84 +0.66%$117.2B mkt cap
Score DNA
Price, rebased to 100 three years ago
COR CAH MCK · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Insider open-market buys, 180d | 3 | 0 | 0 |
| Insider $ bought, 180d | $2.31M | — | — |
| Congress purchases, 180d | 2 | 1 | 4 |
| Last Congress purchase | 2026-09-04 | 2026-03-27 | 2026-08-10 |
| 13F net change in holders | −86 | +66 | — |
| ETFs adding shares, 30d | 1,204 | 1,216 | 1,190 |
| ETFs trimming, 30d | 1,117 | 1,064 | 1,165 |
| Net ETF funds, 30d | +87 | +152 | +25 |
Valuation
16 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| P/E (TTM) | 24.8x | 34.3x | 25.5x |
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.39 | 0.37 | 2.13 |
| Price / sales | 0.2x
0th
|
0.2x
25th
|
0.3x
50th
|
| Price / book | 21.3x | — | — |
| Price / tangible book | — | — | — |
| Price / free cash flow | 16.0x | 13.0x | 18.9x |
| Price / operating cash flow | 13.5x | 11.4x | 17.1x |
| Enterprise value | $74.0B
75th
|
$63.9B
50th
|
$123.7B
100th
|
| EV / sales | 0.2x
0th
|
0.3x
25th
|
0.3x
50th
|
| EV / EBITDA | 14.4x | 18.4x | 16.9x |
| EV / EBIT | 18.1x | 25.3x | 18.8x |
| EV / free cash flow | 18.2x | 14.1x | 20.0x |
| Earnings yield | 4.0%
75th
|
2.9%
25th
|
3.9%
50th
|
| FCF yield | 6.2%
75th
|
7.7%
100th
|
5.3%
25th
|
| Operating cash flow yield | 7.4%
75th
|
8.8%
100th
|
5.8%
25th
|
| Graham number (per share) | $69.21 | — | — |
Profitability (TTM)
12 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Gross margin | 3.7%
50th
|
3.8%
75th
|
3.6%
25th
|
| EBITDA margin | 1.5%
50th
|
1.4%
25th
|
1.8%
75th
|
| Operating margin | 1.3%
50th
|
1.0%
25th
|
1.6%
75th
|
| EBIT margin | 1.2%
50th
|
1.0%
25th
|
1.6%
75th
|
| Net margin | 0.8%
50th
|
0.7%
25th
|
1.1%
75th
|
| NOPAT margin | 1.0%
50th
|
0.8%
25th
|
1.3%
75th
|
| FCF margin | 1.2%
25th
|
1.8%
75th
|
1.5%
50th
|
| Operating cash flow margin | 1.4%
25th
|
2.0%
75th
|
1.7%
50th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 2.3%
25th
|
2.4%
50th
|
1.0%
0th
|
| Stock comp / revenue | 0.0%
50th
|
0.1%
75th
|
0.0%
0th
|
| Effective tax rate | 26.8%
100th
|
21.6%
50th
|
17.9%
0th
|
Returns on capital
11 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| ROE (on average equity) | 104.3% | — | — |
| ROA | 3.3%
50th
|
3.1%
25th
|
5.4%
100th
|
| ROIC | 26.5%
50th
|
92.8%
75th
|
237.7%
100th
|
| ROCE | 16.6%
50th
|
18.8%
75th
|
36.6%
100th
|
| Return on tangible assets | 5.2%
50th
|
4.6%
25th
|
7.7%
100th
|
| Cash ROIC (OCF / invested capital) | 40.3%
50th
|
234.2%
75th
|
298.3%
100th
|
| Gross profitability (GP / assets) | 14.7%
25th
|
17.1%
75th
|
16.9%
50th
|
| ROIC, 3-yr average | 23.8% | — | 142.0% |
| ROIC, 5-yr average | 31.7% | — | — |
| ROE, 5-yr average | 184.3% | — | — |
| Incremental ROIC | 39.2%
25th
|
164.7%
75th
|
-567.2%
0th
|
Growth
17 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Revenue growth (TTM YoY) | 5.1%
0th
|
14.2%
75th
|
8.8%
50th
|
| Revenue growth (QoQ) | 8.2%
75th
|
4.8%
50th
|
9.4%
100th
|
| Revenue CAGR, 3 yr | 9.4%
75th
|
7.4%
50th
|
13.1%
100th
|
| Revenue CAGR, 5 yr | 10.2%
50th
|
9.4%
25th
|
10.9%
75th
|
| Gross profit CAGR, 3 yr | 12.7% | 12.4% | 8.4% |
| Operating income CAGR, 3 yr | 23.2% | 53.2% | 14.6% |
| Net income growth (TTM YoY) | 38.3% | 9.8% | 45.1% |
| Net income CAGR, 3 yr | 15.8% | 87.3% | 7.0% |
| EPS growth (TTM YoY) | 39.3% | 11.2% | 52.8% |
| EPS CAGR, 3 yr | 17.9% | 91.6% | 12.0% |
| EPS CAGR, 5 yr | — | 28.2% | — |
| FCF growth (TTM YoY) | 116.5% | 144.6% | 9.2% |
| FCF CAGR, 3 yr | 13.3% | 24.3% | 11.5% |
| Operating cash flow CAGR, 3 yr | 14.1% | 22.1% | 10.7% |
| Book value CAGR, 3 yr | 51.6% | — | — |
| Dividend CAGR, 3 yr | 4.6% | 2.1% | 8.5% |
| Sustainable growth rate | 85.7% | — | — |
Margin history & stability
7 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Gross margin, 3-yr average | 3.5%
25th
|
3.6%
50th
|
3.6%
75th
|
| Operating margin, 3-yr average | 1.1%
50th
|
0.9%
25th
|
1.3%
75th
|
| Net margin, 3-yr average | 0.7%
50th
|
0.6%
25th
|
1.0%
75th
|
| FCF margin, 3-yr average | 0.9%
25th
|
1.3%
50th
|
1.3%
75th
|
| Revenue stability (0-1) | 0.99
100th
|
0.94
50th
|
0.94
75th
|
| Earnings stability (0-1) | 0.53
25th
|
0.57
50th
|
0.65
75th
|
| Margin stability (0-1) | 0.93
75th
|
0.90
50th
|
0.85
25th
|
Liquidity (latest quarter)
7 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Cash & short-term investments | $2.8B
50th
|
$4.9B
75th
|
$5.2B
100th
|
| Net cash (− = net debt) | −$8.9B
0th
|
−$5.1B
50th
|
−$6.5B
25th
|
| Working capital | −$3.9B
50th
|
−$5.2B
25th
|
−$7.5B
0th
|
| Current ratio | 0.93
50th
|
0.88
0th
|
0.89
25th
|
| Quick ratio | 0.58
50th
|
0.49
0th
|
0.52
25th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.05
50th
|
0.11
100th
|
0.07
75th
|
| Defensive interval (days) | 1,288 days
75th
|
952 days
50th
|
1,560 days
100th
|
Leverage & solvency (latest quarter)
13 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Total debt | $11.7B
100th
|
$9.9B
50th
|
$11.7B
75th
|
| Debt / equity | 3.84 | — | — |
| Net debt / equity | 2.92 | — | — |
| Debt / assets | 14.0%
50th
|
17.4%
75th
|
13.2%
25th
|
| Debt / capital | 79.3% | — | — |
| Debt / EBITDA | 2.28 | 2.86 | 1.59 |
| Net debt / EBITDA | 1.73 | 1.46 | 0.89 |
| Interest coverage (EBIT / interest) | 8.2x | 7.2x | 43.0x |
| Cash interest coverage | 9.7x | 14.9x | 44.8x |
| Debt payback (years of OCF) | 2.4 yrs | 1.9 yrs | 1.7 yrs |
| Liabilities / assets | 96.1%
50th
|
104.8%
100th
|
104.4%
75th
|
| IS credit model rating | A+ | B- | AA+ |
| Implied credit spread (bps) | 125
25th
|
900
100th
|
65
0th
|
Efficiency
11 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Asset turnover | 4.22
50th
|
4.61
75th
|
4.85
100th
|
| Fixed asset turnover | 117.25
75th
|
63.21
25th
|
88.86
50th
|
| Inventory turnover | 15.6
75th
|
14.3
25th
|
15.4
50th
|
| Receivables turnover | 13.3
50th
|
18.8
100th
|
14.1
75th
|
| Days sales outstanding | 27 days
50th
|
19 days
0th
|
26 days
25th
|
| Days inventory outstanding | 23 days
25th
|
25 days
75th
|
24 days
50th
|
| Days payables outstanding | 60 days
100th
|
54 days
50th
|
56 days
75th
|
| Cash conversion cycle (days) | −9 days
25th
|
−10 days
0th
|
−6 days
50th
|
| Capex / revenue | 0.2%
50th
|
0.3%
75th
|
0.2%
25th
|
| Capex / depreciation | 0.71
75th
|
0.68
50th
|
0.87
100th
|
| Operating expense ratio | 2.9%
25th
|
3.2%
50th
|
2.2%
0th
|
Cash flow & earnings quality
7 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Operating cash flow / net income | 1.84 | 3.02 | 1.49 |
| FCF / net income | 1.55 | 2.64 | 1.35 |
| FCF / operating cash flow | 84.2% | 87.5% | 90.3% |
| Capex / operating cash flow | 15.8% | 12.5% | 9.7% |
| Accruals ratio | -2.8%
50th
|
-6.3%
25th
|
-2.7%
75th
|
| Sloan accruals ratio | 0.3%
100th
|
-6.5%
0th
|
-0.9%
75th
|
| Earnings quality score (0-1) | 1.00 | 0.75 | 1.00 |
Scores & forensic checks
15 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| IS score | 60
75th
|
59
50th
|
60
100th
|
| IS profitability | 26
75th
|
6
25th
|
8
50th
|
| IS growth | 72
75th
|
68
50th
|
75
100th
|
| IS value | 44
75th
|
41
25th
|
49
100th
|
| IS momentum | 88
75th
|
84
50th
|
90
100th
|
| IS risk (safety) | 100
25th
|
100
25th
|
100
25th
|
| IS quality | 48
25th
|
57
50th
|
58
75th
|
| IS balance sheet | 39
25th
|
42
50th
|
47
75th
|
| IS earnings quality | 87
75th
|
82
50th
|
87
100th
|
| IS cash flow | 63
75th
|
65
100th
|
59
25th
|
| Piotroski F-score (0-9) | 7
25th
|
8
75th
|
8
75th
|
| Altman Z-score | 4.6
25th
|
5.1
50th
|
5.7
75th
|
| Beneish M-score | −2.69
50th
|
−2.80
25th
|
−2.53
100th
|
| Ohlson O-score | −5.88
75th
|
−6.84
50th
|
−7.15
25th
|
| IS credit score | 80
75th
|
20
0th
|
91
100th
|
Size (TTM)
8 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| Market cap | $65.1B
75th
|
$58.8B
50th
|
$117.2B
100th
|
| Revenue | $332.8B
75th
|
$254.2B
50th
|
$411.0B
100th
|
| EBITDA | $5.1B
75th
|
$3.5B
50th
|
$7.3B
100th
|
| Net income | $2.6B
75th
|
$1.7B
50th
|
$4.6B
100th
|
| Free cash flow | $4.1B
50th
|
$4.5B
75th
|
$6.2B
100th
|
| Total assets | $83.8B
75th
|
$57.3B
50th
|
$88.3B
100th
|
| Shareholders' equity | $3.1B
75th
|
−$2.9B
25th
|
−$4.2B
0th
|
| Employees | 49,000
75th
|
61,344
100th
|
42,300
50th
|
Price performance
9 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| 1 day | −0.2% | +0.1% | +0.7% |
| 1 week | +5.3% | +6.9% | +7.1% |
| 1 month | +10.2% | +12.5% | +14.3% |
| 3 months | +12.1% | +12.8% | +20.9% |
| 6 months | +4.1% | +19.3% | +16.0% |
| Year to date | +0.8% | +24.4% | +22.2% |
| 1 year | +6.8% | +64.8% | +27.1% |
| 3 years, cumulative | +84.8% | +189.3% | +122.4% |
| 5 years, cumulative | +192.7% | +477.4% | +413.7% |
Technicals
4 measures| Measure | COR | CAH | MCK |
|---|---|---|---|
| RSI 14 | 70.0 | 74.3 | 75.8 |
| From 52-week high | −9.7% | −1.4% | −0.7% |
| From 52-week low | +39.6% | +68.2% | +38.9% |
| Beta | 0.58 | 0.50 | 0.30 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17